Shares of Sino-Global Shipping America, Ltd. (NASDAQ:SINO) have been recently spotted trading -68.28% off of the 52-week high price. On the other end, company shares have been noted 64.29% away from the low price over the last 52-weeks. 52 week range of the stock remained $ 0.28 – 1.45. Switching over to some distances from popular moving averages, we see that the stock has been recorded 1.82% away from the 50 day moving average and -28.16% away from the 200 day moving average. Moving closer, we can see that shares have been trading 3.61% off of the 20-day moving average.
The USA based company BIOLASE, Inc. moved with change of -6.12% to $0.46 with the total traded volume of 221120 shares in recent versus to an average volume of 175.86K. The stock was up in the 5 days activity 3.63%. The one month performance of stock was high 2.20%. BIOL shares are above 8.24% for the quarter and driving a -61.67% over the course of the past year and is now up 7.88% since this point in 2018. Right now BIOL beta is 1.76. The average volatility for the week and month was at 9.00% 8.50% respectively.
Sino-Global Shipping America, Ltd. (NASDAQ:SINO) recently announced the closing of its previously announced registered direct offering and concurrent private placement with certain accredited investors to purchase a total of $3 million of its common stock, Series A Warrants and Series B Warrants.
Maxim Group LLC acted as sole placement agent for the offering.
After deducting the placement agent’s commission and other estimated offering expenses payable by Sino-Global, the net proceeds to the Company were approximately $2.6 million. Sino-Global intends to use the net proceeds of the offering for general corporate purposes and working capital.
The common stock sold in the registered direct offering was old pursuant to a shelf registration statement on Form S-3 (File No. 333-222098), previously filed with the Securities and Exchange Commission (the “SEC”) on December 15, 2017 and declared effective on February 16, 2018. A prospectus supplement dated March 12, 2018 and the accompanying prospectus relating to and describing the terms of the registered direct offering was filed with the SEC on March 13, 2018. The Series A Warrants and Series B Warrants, sold in the concurrent private placement, together with the underlying common stock, have not been registered under the Securities Act of 1933, as amended. Copies of the prospectus supplement and the accompanying prospectus relating to the registered direct offering may be obtained at the SEC’s website www.sec.gov or by contacting Maxim Group LLC, 405 Lexington Avenue, 2nd Floor, New York, NY 10174, at 212-895-3745.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction.